로딩 중…
지수 로딩 중…
현대바이오랜드
052260· KOSDAQ· Consumer Staples· Household & Personal Products
₩3,600-0.96%
2026-06-19
Price Chart
현대바이오랜드-29.13%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 108.00B KRW |
| Revenue | 135.04B KRW |
| Net Income | -1.77B KRW |
| Total Assets | 161.49B KRW |
| Net Assets | 139.64B KRW |
| Employees | 347 |
| Value | |
| P/B | 0.77x |
| P/S | 0.80x |
| FCF Yield | 14.33% |
| Profitability | |
| ROE | -1.27% |
| ROA | -1.09% |
| Op. Margin | -1.67% |
| Revenue Growth | 13.45% |
| Financial Health | |
| Debt Ratio | 115.64% |
| Total Debt | 6.00B KRW |
| FCF | 15.48B KRW |
| Cash | 8.27B KRW |
| Current Ratio | 4.49x |
| Dividend | |
| Div. Yield | 1.93% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -29.13% |
| 1M Return | -9.89% |
| From 52W High | -33.58% |
| 1Y MDD | -33.71% |
| Trading | |
| Volume | 221,826 shares |
| Foreign Own. | 2.40% |
| Per Share | |
| EPS | 416 KRW |
| BPS | 4,655 KRW |
Company Info
Hyundaibioland was established in 1995 to manufacture and sell natural product cosmetic and functional food ingredients, listing on KOSDAQ in 2001. The company operates in cosmetic ingredients, health functional foods, pharmaceutical ingredients, medical devices, and brand distribution, leveraging natural-derived biomaterials. It focuses on discovering natural materials and R&D to enhance global competitiveness and develop next-generation Big Items through convergence technology, in response to stricter environmental regulations. Hyundaibioland is headquartered in Cheongju-si, Chungcheongbuk-do.